Camilla Veronica Simpson

Collaborator
DISC Type : is

Member at Biotech CEO Sisterhood

Mill Valley, California, United States

Overview

Camilla is a C-level biotech executive with a proven track record of bringing novel products for multiple diseases to global markets. Educated at the University of Galway and the University of London, she is the founding CEO of Zehna Therapeutics, a Cleveland Clinic spin-out developing small molecule inhibitors for CKD and CVD.

She is a member of the Biotech CEO Sisterhood, indicating a passion for connecting with and supporting fellow female executives in her field. Camilla also actively engages with developments in the broader biotech space, sharing updates on strategic alliances within her network.

Unique fact: Camilla co-authored publications on a novel, small molecule inhibitor that slows the loss of kidney function in rat models of Chronic Kidney Disease.

Personality Overview

Consensus Builder

Fair-minded

Good Listener

Win-win scenarios can appeal strongly to them.  Unlike D or C types, they are calm as well as friendly and can give the impression of being more receptive than they actually are. They are more likely to go for proven solutions.

Topics They Care About

Novel Therapeutics
As CEO of Zehna Therapeutics, she is focused on developing small molecule inhibitors for chronic kidney and cardiovascular diseases, building upon discoveries from the Cleveland Clinic.
Gut Microbiome
Her recent publications focus on inhibiting gut microbial enzymes as a therapeutic strategy for slowing the progression of Chronic Kidney Disease.
Biotech Leadership
She is a member of the Biotech CEO Sisterhood and was featured in Partnology's "Biotech Leader Spotlight Series" to discuss her career path from regulatory leader to CEO.

Media Appearances

Camilla has no verified media appearances

Work History

7-2024
Member at Biotech CEO Sisterhood
4-2023
Independent Board Member at GRI Bio, Inc.
4-2021
Chief Executive Officer at Zehna Therapeutics Inc
12-2020
Independent Board Member at Dyve Biosciences
4-2019
Managing Member and President at Rare Strategic, LLC

Education

BSc from University of Galway
MSc with Distinction from Birkbeck, University of London

More Information

Social Presence :

Prographics :

Exp : 6 Location : Mill Valley, California, United States Job Level : Leadership Designation : Member at Biotech CEO Sisterhood
URL has been copied!

Insights For Selling To Camilla Veronica

During A Call Or A Meeting

DO's

  • Summarize the key points at the end of the conversation
  • Use phrases like ‘trust me when’, ‘your team will love’ etc.
  • If possible, involve their colleagues in the sales process

DONT's

  • Don’t push them to make decisions very fast, let them take their time
  • Don’t sound very transactional
  • Don’t ask too many questions that sound too dry and objective

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Camilla Veronica is

  • Relationship and rapport play a major role, followed by low risk and the presence of proof points.
  • Will you ever get a clear answer from Camilla Veronica

  • They are diplomatic when the need arises; they hardly ever say a direct no.

Insights For Deal Planning

    How fast (or slow) will Camilla Veronica move?

  • They can take their time to reach decisions, even while they stay engaged and friendly.
  • Can Camilla Veronica take some risk or not?

  • They are unlikely to take many risks.

You And Camilla Veronica

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.